<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02286739</url>
  </required_header>
  <id_info>
    <org_study_id>102</org_study_id>
    <nct_id>NCT02286739</nct_id>
  </id_info>
  <brief_title>Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During TKA</brief_title>
  <official_title>Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthosensor, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orthosensor, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of the study are twofold: 1) Evaluate how intra-operative sensing may assist
      the surgeon with tibiofemoral rotational alignment by testing the precision and variability
      of setting tray rotation to the mid-third of the tibial tubercle. 2) Understand if patients
      with a combined axial rotation couple at the tibiofemoral joint and quantitative
      intercompartmental balance, achieved with the use of VERASENSE, exhibit less post-operative
      knee pain and improved clinical outcomes. Radiographic outcomes will also be assessed to
      measure post-operative alignment and to evaluate the prevalence and location of radiolucency
      and/or osteolysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: TKA with VERASENSE results in a more reliable and precise option for establishing
      implant-to-implant congruency and joint balance leading to less knee pain, faster return to
      normal activities and higher patient satisfaction compared to TKA without VERASENSE.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Society Pain and Functional Scoring</measure>
    <time_frame>Changes from baseline at 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior Knee Pain Evaluation</measure>
    <time_frame>Changes from baseline at 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ5D</measure>
    <time_frame>Changes from baseline at 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forgotten Joint Score</measure>
    <time_frame>Changes from baseline at 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Group A TKA without VERASENSE</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>will consist of 250 consecutive patients who will undergo primary PCL-retaining or - sacrificing TKA without the use of VERASENSE to guide rotational alignment and balance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B TKA with VERASENSE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will consist of 250 consecutive patients who will undergo primary PCL-retaining or - sacrificing TKA with the use of VERASENSE to guide rotational alignment and balance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TKA with &quot;Verasense&quot;</intervention_name>
    <description>VERASENSE replaces the standard tibial trial inserts and is embedded with microelectronics and sensors to provide surgeons with real-time knee kinetic data. The data is wirelessly transmitted to a graphic display (VERASENSE Knee Application), allowing surgeons to quantify and assess soft tissue intercompartmental loads throughout the range of motion. The VERASENSE sensor is not an investigational device. OrthoSensor, Inc., received FDA 510K clearance in 2009. The indication for use is a tool for adjustment of the femoral knee implant to reduce instability from flexion gap asymmetry. The VERASENSE sensor is sterile and single patient use.</description>
    <arm_group_label>Group B TKA with VERASENSE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TKA without &quot;Verasense&quot;</intervention_name>
    <description>TKA will be performed manually without the use of Verasense</description>
    <arm_group_label>Group A TKA without VERASENSE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who meet the indications for use for Triathlon® Total Knee System using
             VERASENSE™

          -  Subject must be diagnosed with one or more of the following conditions

          -  osteoarthritis

          -  rheumatoid or other inflammatory arthritis

          -  post-traumatic arthritis

          -  Subject is likely to be available for all study visits

          -  Subject is able and willing to sign the informed consent and follow study procedures

        Exclusion Criteria:

          -  Prior Total Knee Arthroplasty

          -  Avascular Necrosis

          -  Any knee surgery other than meniscectomy (can be arthroscopic or open)

          -  Ligament insufficiencies, prior surgeries such as ACL or PCL reconstructions,
             posterolateral reconstructions, osteotomies, tibia plateau fractures

          -  Ipsilateral foot/ankle and hip arthritis

          -  Range of motion less than 90°, flexion contracture greater than 20°

          -  Subject has a mental condition that may interfere with the subject's ability to give
             an informed consent or willingness to fulfill the study requirements (i.e., severe
             mental retardation such that the Subject cannot understand the informed consent
             process, global dementia, prior strokes that interfere with the Subject's cognitive
             abilities, senile dementia, and Alzheimer's Disease)

          -  Any subjects meeting any contraindication criteria as identified in the locally
             approved labeling for the device should be excluded from this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christopher R. Anderson, MS, MBA</last_name>
    <phone>(954) 372-2641</phone>
    <email>canderson@orthosensor.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leah C. Elson, BS</last_name>
    <phone>954-577-7770</phone>
    <email>lelson@orthosensor.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecilia Calvo</last_name>
      <email>calvoc@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Preetesh Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jared O'Neal</last_name>
      <email>jwoneal@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Bradbury, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Illinois Bone &amp; Joint Institute</name>
      <address>
        <city>Morton Grove</city>
        <state>Illinois</state>
        <zip>60053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy R Cipparrone</last_name>
      <email>ncipparrone@ibji.com</email>
    </contact>
    <investigator>
      <last_name>Alexander Gordon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Hospital for Joint Diseases</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariel Aponte, CCRC</last_name>
      <email>ariel.aponte@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Ivan Fernandez-Madrid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gannon Curtis, MD</last_name>
      <email>curtisg@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Wael Barsoum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Hansen</last_name>
      <email>mhansen@mcvh-vcu.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Golladay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2014</study_first_submitted>
  <study_first_submitted_qc>November 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2014</study_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Knee Arthroplasty</keyword>
  <keyword>Rotational Alignment</keyword>
  <keyword>Intraoperative Sensors</keyword>
  <keyword>Patient Outcomes</keyword>
  <keyword>Soft Tissue Balance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

